Signostics receives FDA clearance for world’s smallest ultrasound
5 June 2009
Signostics has secured clearance from the US FDA for its palm-sized
personal ultrasound product, the Signos. Signostics’
device makes it affordable for individual healthcare professionals to
use ultrasound in their clinical practice. This breakthrough product is
the first ultrasound platform technology that clinicians can place in
their pocket or wear around their neck like a stethoscope.
Just as handheld devices transformed the business world, Signostics
anticipates that the Signos will change the way healthcare professionals
Retailing at a fraction of the cost of larger machines, the Signos is
the world’s smallest and lightest ultrasound product. With a weight of
approximately half a pound, its portability and low price point appeals
to a large range of medical markets, including emergency medicine,
primary care, remote healthcare, critical care, pediatrics, musculo-skeletal,
palliative care and sports medicine.
“Securing FDA clearance is a huge milestone for our company,” said
Signostics Chief Executive Officer Dr Neil Bartlett. “The global
financial crisis over the last six months has put pressure on health
costs around the world and increased the need for more affordable
medical products that can deliver results rapidly and conveniently. The
Signos meets these requirements and physician interest in the product at
industry events and among industry leaders has been remarkable. We are
very optimistic about the sales outlook for the company.”
According to McGregor Tan Research in their 2005 Market Assessment,
the global personal ultrasound market is estimated to be worth around $3
billion, with the US market worth about $1 billion.
“Signostics overcame some difficult product design challenges in
developing its innovative palm-sized, portable ultrasound product,” said
Patrick O’Doherty, healthcare segment director, Analog Devices, Inc.
(NYSE: ADI), a global leader in high-performance semiconductors for
signal-processing applications and longtime collaborator with the
medical imaging industry.
“Analog Devices worked closely with Signostics to provide key signal
processing technologies for the data conversion, signal conditioning and
sensing necessary to achieve their design. We congratulate Signostics on
receiving FDA clearance to market the revolutionary Signos personal
The Signos delivers high-resolution images anywhere, at any time for
general medical applications, including: abdominal assessments such as
bladder, abdominal aortic aneurysm screening, and trauma assessment;
musculoskeletal; and basic obstetrics, such as pregnancy viability and
Signostics has received funding from angel investors, Australian
government grant providers and Playford Capital. The company will
shortly close a round of funding at almost $4 million, having raised a
total of $12 million to date.
The brainchild of physician-engineer Dr Neil Bartlett, Signostics was
established in Adelaide, Australia in January 2005. Signostics employs a
cutting-edge development team including physicians, sonographers as well
as biomedical, electronic and software engineers. Signostics’ global
sales and marketing headquarters is located in the United States in
Silicon Valley, California.
Bookmark this page